Artículos por temáticas

FGF21 Protects Dopaminergic Neurons in Parkinson's Disease Models Via Repression of Neuroinflammation

Fang X, Ma J, Mu D, Li B, Lian B, Sun C.

Neurotox Res. 2020 Mar;37(3):616-627. doi: 10.1007/s12640-019-00151-6. Epub 2020 Jan 29.

Trichloroethylene, a ubiquitous environmental contaminant in the risk for Parkinson's disease

De Miranda BR , Greenamyre JT .

Environ Sci Process Impacts. 2020 Mar 1;22(3):543-554. doi: 10.1039/c9em00578a. Epub 2020 Jan 30.

Advancement in the modelling and therapeutics of Parkinson's disease

Rai SN, Singh P.

J Chem Neuroanat. 2020 Jan 26;104:101752. doi: 10.1016/j.jchemneu.2020.101752. Online ahead of print.

Prediction of Freezing of Gait in Patients With Parkinson's Disease by Identifying Impaired Gait Patterns

Zhang Y, Yan W, Yao Y, Ahmed JB, Tan Y, Gu D.

IEEE Trans Neural Syst Rehabil Eng. 2020 Mar;28(3):591-600. doi: 10.1109/TNSRE.2020.2969649. Epub 2020 Jan 27.

Physical Therapy for Freezing of Gait and Gait Impairments in Parkinson Disease: A Systematic Review

Rutz DG, Benninger DH.

PM R. 2020 Nov;12(11):1140-1156. doi: 10.1002/pmrj.12337. Epub 2020 May 19.

Sex-dependent association of urate on the patterns of striatal dopamine depletion in Parkinson's disease

Baik K, Chung SJ, Yoo HS, Lee YH, Jung JH, Sohn YH, Lee PH.

Eur J Neurol. 2020 May;27(5):773-778. doi: 10.1111/ene.14152. Epub 2020 Feb 20.

[Anxiety, depression and sleep disorders in Parkinson's disease: a complex interaction between body and mind]

Rutten S, Vriend C, Berendse HW, Van der Werf YD, van den Heuvel OA.

Tijdschr Psychiatr. 2020;62(1):62-72.

Rasagiline and selegiline modulate mitochondrial homeostasis, intervene apoptosis system and mitigate α-synuclein cytotoxicity in disease-modifying therapy for Parkinson's disease

Naoi M, Maruyama W, Shamoto-Nagai M.

J Neural Transm (Vienna). 2020 Feb;127(2):131-147. doi: 10.1007/s00702-020-02150-w. Epub 2020 Jan 28.

MRgFUS Pallidothalamic Tractotomy for Chronic Therapy-Resistant Parkinson's Disease in 51 Consecutive Patients: Single Center Experience

Gallay MN, Moser D, Rossi F, Magara AE, Strasser M, Bühler R, Kowalski M, Pourtehrani P, Dragalina C, Federau C, Jeanmonod D.

Front Surg. 2020 Jan 14;6:76. doi: 10.3389/fsurg.2019.00076. eCollection 2019.

Striatum Shape Hypertrophy in Early Stage Parkinson's Disease With Excessive Daytime Sleepiness

Gong L, Li H, Yang D, Peng Y, Liu D, Zhong M, Zhang B, Xu R, Kang J.

Front Neurosci. 2020 Jan 9;13:1353. doi: 10.3389/fnins.2019.01353. eCollection 2019.

Contrast sensitivity visual acuity in REM sleep behavior disorder: a comparison with and without Parkinson disease

Whitfield WH, Barr GQ, Khayata MJ, Vogt PH, Keasler EM, Sanchez JM, Song Z, Dieujuste M, Cardon B, Riggs R, Pique KN, Merin E, Huang DY, Maitland CG.

J Clin Sleep Med. 2020 Mar 15;16(3):385-388. doi: 10.5664/jcsm.8212. Epub 2020 Jan 14.

Fisetin Improved Rotenone-Induced Behavioral Deficits, Oxidative Changes, and Mitochondrial Dysfunctions in Rat Model of Parkinson's Disease

Alikatte K, Palle S, Rajendra Kumar J, Pathakala N.

J Diet Suppl. 2021;18(1):57-71. doi: 10.1080/19390211.2019.1710646. Epub 2020 Jan 29.

Frontal theta and beta oscillations during lower-limb movement in Parkinson's disease

Singh A, Cole RC, Espinoza AI, Brown D, Cavanagh JF, Narayanan NS.

Clin Neurophysiol. 2020 Mar;131(3):694-702. doi: 10.1016/j.clinph.2019.12.399. Epub 2020 Jan 13.

Genetics of Parkinson's disease: An introspection of its journey towards precision medicine

Bandres-Ciga S, Diez-Fairen M, Kim JJ, Singleton AB.

Neurobiol Dis. 2020 Apr;137:104782. doi: 10.1016/j.nbd.2020.104782. Epub 2020 Jan 25.

Local field potential dynamics in the primate cortex in relation to parkinsonism reveled by machine learning: A comparison between the primary motor cortex and the supplementary area

Darbin O, Hatanaka N, Takara S, Kaneko M, Chiken S, Naritoku D, Martino A, Nambu A.

Neurosci Res. 2020 Jan 25:S0168-0102(20)30015-8. doi: 10.1016/j.neures.2020.01.012. Online ahead of print.